https://www.marketscreener.com/quote/stock/SANGAMO-THERAPEUTICS-INC-10811/news/Sangamo-Therapeutics-Bioverativ-and-Sangamo-Announce-FDA-Acceptance-of-IND-Application-for-Gene-Ed-26595833/?utm_source=telegram&utm_medium=social&utm_campaign=share